These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 33432193)

  • 1. Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.
    Leng K; Li E; Eser R; Piergies A; Sit R; Tan M; Neff N; Li SH; Rodriguez RD; Suemoto CK; Leite REP; Ehrenberg AJ; Pasqualucci CA; Seeley WW; Spina S; Heinsen H; Grinberg LT; Kampmann M
    Nat Neurosci; 2021 Feb; 24(2):276-287. PubMed ID: 33432193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
    Botez G; Probst A; Ipsen S; Tolnay M
    Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta, tau, and dementia.
    Takashima A
    J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease.
    Leuba G; Wernli G; Vernay A; Kraftsik R; Mohajeri MH; Saini KD
    Dement Geriatr Cogn Disord; 2005; 19(4):171-83. PubMed ID: 15677864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.
    Benzing WC; Mufson EJ
    Exp Neurol; 1995 Apr; 132(2):162-71. PubMed ID: 7540552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F; Kobayashi K; Nakamura I
    Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging-Related Calcium Dysregulation in Rat Entorhinal Neurons Homologous with the Human Entorhinal Neurons in which Alzheimer's Disease Neurofibrillary Tangles First Appear.
    Gant JC; Kadish I; Chen KC; Thibault O; Blalock EM; Porter NM; Landfield PW
    J Alzheimers Dis; 2018; 66(4):1371-1378. PubMed ID: 30412490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
    Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
    Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM
    Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
    García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
    Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Alzheimer-type lesions in cognitively normal subjects.
    Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
    Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.
    Koppel J; Acker C; Davies P; Lopez OL; Jimenez H; Azose M; Greenwald BS; Murray PS; Kirkwood CM; Kofler J; Sweet RA
    Neurobiol Aging; 2014 Sep; 35(9):2021-8. PubMed ID: 24731519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas and Fas ligand expression in Alzheimer's disease.
    Ferrer I; Puig B; Krupinsk J; Carmona M; Blanco R
    Acta Neuropathol; 2001 Aug; 102(2):121-31. PubMed ID: 11563626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.
    Fujino Y; Wang DS; Thomas N; Espinoza M; Davies P; Dickson DW
    J Neuropathol Exp Neurol; 2005 Mar; 64(3):209-14. PubMed ID: 15804052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.